Novel linker strategy techniques to increase efficacy of ADC products

March 5, 2012 - PRLog -- Antibody Drug Conjugates are used to fight cancerous cells and are made up of the antibody that will target a specific tumour0-associated antigen a drug often described as payload and the linker. This results in a drug being delivered selectively to the appropriate malignant cell due to the antibody targeting and specific antigen

Join SMi at their inaugural ADC Summit held on the 23rd & 24th May 2012 in london that will focus on the current ADC pipeline and present attendees with an in-depth view into novel innovations, developments and utilities of antibody-drug conjugates. The 2012 speaker line up, with key experts from all sectors of the industry will provide attendees with a unique insight into latest technological and scientific developments and will be the perfect platform for debate and problem-solving discussion.

Don’t miss this exciting opportunity to network with key industry expert such as

John Flygare, Senior Scientist, Genentech
John Lambert, CSO, Immunogen
Jonathan Drachman, Senior VP, Research and Translational Medicine, Seattle Genetics
Wen Jin Wu, Principal Investigator, Divison of Monoclonal Antibodies, FDA
Michel Awwad, Senior Director, Pfizer
Andrew Polson, Senior Scientist, Genentech
Leonard Reyno, Senior Vice President, Chief Medical Officer, Agensys
Vincent de Groot, Vice President, Antibody Drug Conjugates, Synthon
Goncalo Bernardes, EMBO & Novartis Fellow in Cancer Research, Swiss Institute of Technology
Katherine Kozak, Scientist, Biochemical and Cellular Pharmacology, Genentech
Mahendra Deonarain, Honorary Reader in Antibody Technology, Imperial College London
Christopher Scott, Director of Research, School of Pharmacy, Queen's University Belfast
Katherine Vallis, Professor of Experimental Radiotherapeutics, University of Oxford
Edwin Bremer, Assistant Professor, University Medial Center, Groningen
Giulio Casi, Head of Antibody Drug Cojugate Development, Philochem
Justin Mason, Managing Director, Safebridge Europe

For more information visit http://www.smi-online.co.uk/adcsummit24.asp
Alternatively contact Fateja Begum on fbegum@smi-online.co.uk or tel. +44 0207 827 6184